Please assess the completion status of the following clinical trial:

Trial Title: Effect of Luteal Progesterone Support on Pregnancy Rates With Combined Clomid/ Gonadotropin & IUI

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-37~* BMI 19-34 kg/m2~* Day 2-3 Follicle stimulating hormone (FSH) less than 10IU/mL~* Estradiol (E2) less than 80 pg/mL~* Anti-mullerian hormone (AMH) more than 1.5 ng/mL; or antral follicle count (AFC) up to 10~* Two patent fallopian tubes confirmed by hysterosalpingogram (HSG) or chromopertubation~* Normal uterine cavity confirmed by HSG, saline sonohysterogram (SIS) or hysteroscopy~Exclusion Criteria:~* Severe male factor (total count less than 10 million sperm)~* Systemic diseases not limited to diabetes~* Pregnancy within 3 months~* More than 1 prior cycle of gonadotropin treatment~* Any ovarian cyst \>15mm that has persisted for \> 1 month~* Endometrioma and/or Endometriosis-stage III or IV~* Submucosal uterine fibroids; untreated endometrial polyps \>1 cm;abnormal reproductive tract bleeding~* Intolerance or allergy to study drug~* Substance abuse (including alcohol and tobacco)~* History of chemotherapy (except for gestational conditions) or radiotherapy~* Minors and those adults not capable of consenting on their own

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 37 Years
- Healthy Volunteers: t

Study Arms:
- Control (Type: ACTIVE_COMPARATOR): This arm receives Menopur 150 international units x 1 dose
- Treatment (Type: ACTIVE_COMPARATOR): This arm receives Menopur 150 international units x 1 dose and Endometrin 100mg twice a day x 14 days

Based on this trial design, predict the completion outcome and termination type (if applicable).